IUAAX
Price
$41.99
Change
-$0.82 (-1.92%)
Updated
Dec 18 closing price
RIDAX
Price
$24.08
Change
-$0.53 (-2.15%)
Updated
Dec 18 closing price
Ad is loading...

IUAAX vs RIDAX

Header iconIUAAX vs RIDAX Comparison
Open Charts IUAAX vs RIDAXBanner chart's image
VY® Invesco Equity and Income A
Price$41.99
Change-$0.82 (-1.92%)
VolumeN/A
CapitalizationN/A
American Funds Income Fund of Amer R1
Price$24.08
Change-$0.53 (-2.15%)
VolumeN/A
CapitalizationN/A
IUAAX vs RIDAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IUAAX vs. RIDAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IUAAX is a Sell and RIDAX is a Buy.

FUNDAMENTALS
Fundamentals
RIDAX has more cash in the bank: 126B vs. IUAAX (474M). RIDAX pays higher dividends than IUAAX: RIDAX (2.82) vs IUAAX (1.59). IUAAX was incepted earlier than RIDAX: IUAAX (23 years) vs RIDAX (23 years). IUAAX is a more actively managed with annual turnover of: 144.00 vs. RIDAX (40.00). IUAAX has a lower initial minimum investment than RIDAX: IUAAX (0) vs RIDAX (250). RIDAX annual gain was more profitable for investors over the last year : 10.05 vs. IUAAX (6.12). RIDAX return over 5 years is better than : 17.26 vs. IUAAX (4.82).
IUAAXRIDAXIUAAX / RIDAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD5.2058.72160%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets474M126B0%
Annual Yield % from dividends1.592.8256%
Returns for 1 year6.1210.0561%
Returns for 3 years-12.644.51-280%
Returns for 5 years4.8217.2628%
Returns for 10 years5.4328.1119%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPK1.610.01
+0.62%
OPKO Health
PFG77.54-1.13
-1.44%
Principal Financial Group
HI30.81-0.69
-2.19%
Hillenbrand
VRA3.88-0.10
-2.51%
Vera Bradley
BTAI0.39-0.02
-4.01%
BioXcel Therapeutics